Mefloquine and Artesunate Tablet
Generic Name |
Mefloquine and Artesunate |
---|---|
Strength |
200 mg + 100 mg |
Form |
Tablet |
Packaging |
1 X 10 Tablet |
Therapeutic use |
Anti Malarial |
Manufacturing Period |
30 to 45 Days |
Available Composition of
Name | Strength | Therapeutic use | View More |
---|---|---|---|
Mefloquine and Artesunate Tablet | 200 mg + 100 mg | Anti Malarial | |
Mefloquine Tablet | 250 mg | Anti Malarial | |
Artesunate and Amodiaquine Tablet | 100 mg + 270 mg, 50 mg + 135 mg | Anti Malarial | |
Artesunate, Pyrimethamine and Sulphadoxine Tablet | 100 mg + 25 mg + 500 mg, 200 mg + 37.5 mg + 750 mg | Anti Malarial | |
Artesunate Tablet | 100 mg, 50 mg | Anti-Malarial | |
Artesunate Injection | 120 mg, 60 mg | Anti-Malarial |
Product Description For Mefloquine and Artesunate Tablet
products details and uses
Mefloquine and Artesunate Tablet Exporter India , Manufacturer & Global Supplier
Mefloquine and Artesunate Tablet is a highly effective antimalarial combination used for the treatment of uncomplicated malaria caused by Plasmodium falciparum and other resistant strains of the malaria parasite. This dual formulation provides rapid action through Artesunate and sustained therapeutic coverage through Mefloquine, making it a preferred choice in malaria-endemic regions. As a trusted Mefloquine and Artesunate Tablet Exporter India, we are committed to supplying premium quality formulations that meet international standards of safety, efficacy, and affordability.
Uses of Mefloquine and Artesunate Tablet
-
Treatment of Malaria: Highly effective against chloroquine-resistant Plasmodium falciparum infections.
-
Rapid Relief: Artesunate ensures fast reduction of symptoms such as fever and chills.
-
Prevention of Recurrence: Mefloquine sustains therapeutic activity to reduce relapse chances.
-
Combination Therapy: Recommended by WHO as part of artemisinin-based combination therapies (ACTs).
As a reliable Mefloquine and Artesunate Tablet Exporter India, we ensure our products reach hospitals, NGOs, and healthcare providers across malaria-prone regions in Asia, Africa, and South America.
Precautions
Patients taking Mefloquine and Artesunate Tablet should follow medical guidance strictly. Important precautions include:
-
Should not be taken by individuals with a history of psychiatric disorders, seizures, or cardiac issues.
-
Pregnant women should consult healthcare providers before use.
-
Dosage should never be altered without medical supervision.
-
Patients should inform doctors about any ongoing medications to avoid drug interactions.
-
Not suitable for long-term prophylaxis; primarily intended for therapeutic use.
Being a responsible Mefloquine and Artesunate Tablet Exporter India, we provide detailed product leaflets and labeling to promote safe and effective use worldwide.
Side Effects
Like any medication, Mefloquine and Artesunate Tablet may cause side effects, although not everyone experiences them. Common side effects include:
-
Nausea, vomiting, or diarrhea
-
Dizziness or mild headache
-
Abdominal pain
-
Temporary sleep disturbances
Rare but serious side effects may include mood changes, anxiety, irregular heartbeat, or seizures. Patients should seek immediate medical attention if severe reactions occur. As a transparent Mefloquine and Artesunate Tablet Exporter India, we ensure healthcare professionals are well informed of potential risks.
Why Choose Us as Your Trusted Partner?
-
Leading Mefloquine and Artesunate Tablet Exporter India with global recognition.
-
WHO-GMP certified manufacturing facilities ensuring uncompromised quality.
-
Strong distribution network across malaria-endemic regions.
-
Competitive pricing, making treatments affordable for patients worldwide.
-
Trusted by governments, NGOs, hospitals, and pharmaceutical distributors.
Global Distribution Network
With a strong logistics and compliance framework, we successfully export to a broad range of international markets, including: Venezuela, Brazil, Cambodia, Philippines, Nigeria, Myanmar, Thailand, Singapore, Russia, Kyrgyzstan, Tajikistan, Kenya, Zimbabwe, Somalia, Djibouti, Belarus, Macedonian, And Turkey.